Industry Perspectives

Hospitals must inventory, validate, monitor, and quickly shut down unsafe AI to protect patients.

Make AI failure modes—drift, hallucinations, vendor changes—part of healthcare continuity with human fallbacks, monitoring, and vendor controls.

How AI outages, model drift, and vendor failures can harm patients, and why monitoring, fallback plans, and governance matter.

Guide to intake, tier, contract, validate, and monitor third-party AI to protect patients, PHI, and clinical workflows.

Procurement must assess clinical risk, PHI flows, contracts, and continuous monitoring for AI tools in healthcare.

Manage post-contract healthcare AI risk: monitor SBOMs, subcontractors, and retrained models with one shared lifecycle.

Unseen cloud hosts, model APIs, and subprocessors can expose ePHI; inventory, BAAs, and monitoring mitigate risk.

Explains how layered AI vendors create PHI and patient-safety risks, and outlines governance, contract, and monitoring controls.

Require evidence: AI-BOMs, training-data lineage, supply-chain and security disclosures, and enforceable contracts to manage AI risk and protect patients.

Procurement guide to vet AI vendors handling PHI: verify data use, model validation, subprocessors, and contract controls.

How to evaluate AI supply chains in healthcare: map models, PHI limits, subprocessors, testing, and continuous monitoring.

Hospitals must treat AI vendors as clinical risks—requiring transparency, PHI protections, bias testing, and lifecycle monitoring.

Explains why traditional TPRM fails for AI in healthcare and how to add AI-specific intake, contracts, and continuous monitoring.

HSCC’s third-party AI framework sets a practical baseline for healthcare vendor oversight: inventory, risk scoring, contracts, and monitoring.

AI in healthcare must move from pilots to controlled, auditable operations driven by standards, ownership, and continuous monitoring.

Healthcare orgs must name owners, enforce approval workflows, and keep auditable logs for every AI tool to reduce clinical, legal, and cyber risk.

AI governance must be daily risk work — inventory tools, assign owners, enforce BAAs, and monitor models to protect patient data.

Turns AI governance into repeatable healthcare controls: vendor risk tiers, audit-ready evidence, contracts, and post-deployment monitoring.

Boards must oversee AI in healthcare: inventory, vendor review, local validation, bias checks, monitoring, and incident escalation.

AI governance needs a standards stack, named owners, vendor checks, and active monitoring—not just committees.

ANSI/HSI 2800:2025 makes AI accountability actionable with named owners, lifecycle controls, vendor oversight, and audit-ready records.

ANSI/HSI 2800:2025 makes healthcare AI a board-level issue—CEO execution, vendor scrutiny, auditable reporting, and a 90-day plan.

Explains ANSI/HSI 2800:2025 and practical steps for board-level AI governance: inventories, vendor controls, local validation, risk scoring, and monitoring.

ANSI/HSI 2800:2025 moves healthcare AI to board-led, documented governance — inventories, risk reviews, vendor checks, and continuous monitoring.